Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4M Sell
162,854
-179,188
-52% -$17.8M 0.08% 212
2026
Q1
$32.2M Sell
342,042
-118,028
-26% -$11.8M 0.17% 134
2025
Q4
$45.4M Sell
460,070
-293,262
-39% -$28.4M 0.23% 98
2025
Q3
$63.9M Sell
753,332
-277,789
-27% -$22M 0.33% 74
2025
Q2
$70.2M Buy
1,031,121
+162,576
+19% +$10.3M 0.4% 56
2025
Q1
$52.6M Sell
868,545
-166,107
-16% -$11.6M 0.33% 79
2024
Q4
$71.5M Buy
1,034,652
+224,919
+28% +$16M 0.41% 52
2024
Q3
$53.5M Sell
809,733
-509,948
-39% -$32.5M 0.31% 69
2024
Q2
$80M Sell
1,319,681
-154,116
-10% -$8.73M 0.48% 48
2024
Q1
$84M Buy
1,473,797
+433,508
+42% +$26M 0.54% 35
2023
Q4
$65.3M Buy
1,040,289
+45,951
+5% +$2.6M 0.45% 48
2023
Q3
$57.4M Buy
994,338
+1,134
+0.1% +$71.5K 0.41% 56
2023
Q2
$61.8M Buy
993,204
+156,025
+19% +$10.4M 0.45% 51
2023
Q1
$55.7M Sell
837,179
-30,650
-4% -$2.4M 0.39% 63
2022
Q4
$69.7M Sell
867,829
-53,130
-6% -$4.07M 0.47% 43
2022
Q3
$61.4M Buy
920,959
+180,757
+24% +$13.4M 0.43% 50
2022
Q2
$56.2M Sell
740,202
-11,557
-2% -$878K 0.46% 53
2022
Q1
$59.7M Sell
751,759
-22,683
-3% -$1.65M 0.41% 58
2021
Q4
$56.8M Buy
774,442
+31,702
+4% +$2.14M 0.36% 66
2021
Q3
$51.1M Buy
742,740
+70,846
+11% +$5.38M 0.35% 66
2021
Q2
$56.5M Buy
671,894
+98,596
+17% +$8.22M 0.39% 53
2021
Q1
$47.9M Sell
573,298
-2
-0% -$171 0.4% 57
2020
Q4
$49.9M Buy
573,300
+250,608
+78% +$21.7M 0.39% 57
2020
Q3
$29M Buy
322,692
+2,126
+0.7% +$205K 0.27% 87
2020
Q2
$33.3M Buy
320,566
+30,545
+11% +$2.94M 0.35% 68
2020
Q1
$24.8M Buy
290,021
+18
+0% +$1.36K 0.27% 77
2019
Q4
$25.3M Sell
290,003
-4,188
-1% -$358K 0.27% 77
2019
Q3
$21.8M Sell
294,191
-100,305
-25% -$8.11M 0.29% 68
2019
Q2
$33.4M Sell
394,496
-99,439
-20% -$7.98M 0.42% 49
2019
Q1
$42.5M Buy
493,935
+28,413
+6% +$2.31M 0.54% 37
2018
Q4
$29.6M Buy
465,522
+149,727
+47% +$9.72M 0.45% 47
2018
Q3
$21.8M Buy
315,795
+18,935
+6% +$1.3M 0.29% 76
2018
Q2
$19.9M Buy
296,860
+2,067
+0.7% +$141K 0.31% 74
2018
Q1
$24.6M Sell
294,793
-24,795
-8% -$2.24M 0.42% 56
2017
Q4
$30.3M Sell
319,588
-75,170
-19% -$7.86M 0.52% 36
2017
Q3
$46.1M Buy
394,758
+38,014
+11% +$4.81M 0.81% 18
2017
Q2
$44.9M Buy
356,744
+14,388
+4% +$1.83M 0.84% 17
2017
Q1
$45.8M Sell
342,356
-21,468
-6% -$2.73M 0.89% 17
2016
Q4
$36.5M Sell
363,824
-29,980
-8% -$2.92M 0.84% 18
2016
Q3
$37.1M Buy
393,804
+55,743
+16% +$4.7M 0.89% 17
2016
Q2
$27M Buy
338,061
+64,709
+24% +$5.02M 0.7% 31
2016
Q1
$19.7M Sell
273,352
-5,072
-2% -$378K 0.49% 47
2015
Q4
$30.2M Sell
278,424
-18,960
-6% -$2.11M 0.81% 25
2015
Q3
$32.8M Buy
297,384
+34,212
+13% +$3.84M 0.81% 19
2015
Q2
$27.4M Buy
263,172
+8,304
+3% +$860K 0.57% 38
2015
Q1
$23.4M Buy
254,868
+39,000
+18% +$3.22M 0.47% 50
2014
Q4
$15.8M Buy
+215,868
New +$14.1M 0.33% 96

Other funds holding INCY

Candriam SCA's INCY Position: Q2 2026 in Review

Candriam SCA reduced its Incyte (INCY) stake by 52% in Q2 2026, selling an estimated $17.8M and leaving 162,854 shares worth $18.4M. The position accounts for 0.08% of the portfolio, ranked #212.

Candriam SCA first reported a position in INCY in Q4 2014 and has held it in 47 quarters since. The position peaked at $84M in Q1 2024. 853 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Candriam SCA held 162,854 shares of Incyte worth $18.4M as of Q2 2026.
  • Candriam SCA sold 179,188 Incyte shares in Q2 2026, an estimated $17.8M.
  • Incyte made up 0.08% of Candriam SCA's portfolio in Q2 2026, its #212 holding.
  • Candriam SCA first reported a position in Incyte in Q4 2014 and has held it in 47 quarters since.
  • Candriam SCA's Incyte position peaked at $84M in Q1 2024.
  • 853 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.